"DermDox Dermatology Centers, PC provide a full range of dermatology services for several decades. We diagnose and treat a wide range of skin conditions, from acne to cancer, using the latest medical procedures and techniques. We also offer full-service cosmetic dermatology, including laser treatments, Botox(R), fillers, and tattoo removal. Common skin conditions we treat are: Acne Rosacea Eczema (Atopic dermatitis) Psoriasis Warts Molluscum Contagiosum Moles/Melanoma Photodamage Basal and Squamous cell Carcinoma Fungal infections (ringworm) Itching Keloids Rashes Disorders of pigmentation Poison Ivy Actinic Keratosis"

During the past decade, DermDox Centers for Dermatology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DermDox Centers for Dermatology" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Galderma R&D" with 3 trials sponsored, "Asana BioSciences" with 2 trials sponsored, "ParaPRO LLC" with 2 trials sponsored and "Encube Ethicals Pvt. Ltd." with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DermDox Centers for Dermatology" #1 collaborator was "Concentrics Research" with 2 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator, "Dermira, Inc." with 1 trials as a collaborator, "Inotiv Laboratories" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "DermDox Centers for Dermatology" are "Atopic Dermatitis" (4 trials), "Rosacea" (3 trials), "Psoriasis" (2 trials), "Scabies" (2 trials) and "Actinic Keratoses" (1 trials). Many other conditions were trialed in "DermDox Centers for Dermatology" in a lesser frequency.

Most popular intervention types in "DermDox Centers for Dermatology" are "Drug" (12 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ASN002" (2 trials), "LY3471851" (2 trials), "Brimonidine" (1 trials) and "CD07805/47 Gel" (1 trials). Other intervention names were less common.

The vast majority of trials in "DermDox Centers for Dermatology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "DermDox Centers for Dermatology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in DermDox Centers for Dermatology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in DermDox Centers for Dermatology, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".